From Ideas to IPO: The structured path behind Switzerland’s next listed companies
scroll south
Switzerland’s strongest deeptech startups share more than scientific excellence. They share a development journey that systematically transforms early-stage innovation into globally competitive companies. What begins as a scientific breakthrough rarely starts with public markets in mind. It must be validated, challenged, strategically refined, and strengthened over time. Technology evolves into a scalable business model, founding teams grow into professional organizations, and ambition expands from national relevance to international leadership.
Building the foundation for scale
Through the Venturelab Trainings, founders validate markets, sharpen positioning, and address critical strategic questions at an early stage. Ideas are not simply supported; they are rigorously tested and developed into investor-ready ventures.
As clarity increases, access to smart capital becomes decisive. Venture Kick offers startups a structured, multi-stage pathway toward its 1 Million Plus opportunity. Through successive selection rounds, founders refine their strategy, engage with experienced juries, and increase their visibility among investors. This staged process strengthens capital readiness, reinforces execution discipline, and positions companies for substantial follow-on financing.
With stronger fundamentals in place, international expansion follows. Selected startups join the Venture Leaders roadshows as members of the Swiss National Startup Team, connecting with global investors and industry leaders in key innovation hubs. International benchmarking helps refine strategy and accelerates scaling ambitions.
“As a scientific founder, the educational programs organized and co-organized by Venturelab, such as the SIX IPO Academy, provide very valuable toolboxes that you need during your entrepreneurial path,”
Marc Gitzinger, Co-Founder and CEO of BioVersys.
For companies entering later growth stages, capital market preparation becomes increasingly relevant. In collaboration with SIX, Venturelab co-organizes the SIX IPO Academy, offering practical insights into listing requirements, governance standards, investor relations, and capital market dynamics. The program supports companies in understanding what it takes to transition from high-growth ventures to publicly listed companies.
Onward Medical, Bioversys, and MindMaze illustrate how Swiss technology-driven ventures can evolve from early-stage startups to publicly listed companies.
From ecosystem to outcome
Switzerland’s deeptech pipeline remains strong. Several companies within today’s Top100 Swiss Startup Ranking operate in life sciences, medtech, robotics, AI, and advanced engineering and show significant growth momentum.
The Top100 serves as a forward-looking indicator of market maturity and strategic positioning. Companies featured in the ranking often demonstrate the scale, governance development, and investor backing that typically precede public market opportunities.
“The Top100 highlights the companies defining Switzerland’s next growth wave. Several of tomorrow’s public market stories are already emerging within today’s ranking,”
Markus Hammer, CMO of Venturelab.
From idea validation to international expansion and, for some, to the stock exchange, the journey remains demanding. Within a coherent development framework, however, it becomes a pathway that can be navigated systematically rather than exceptionally.
